Cargando…

Lipopolysaccharide Downregulates CD163 Expression to Inhibit PRRSV Infection via TLR4-NF-κB Pathway

Porcine reproductive and respiratory syndrome virus (PRRSV) has been recognized to induce proinflammatory cytokine production and modulate the host interferon (IFN) system. Proinflammatory cytokines and type I IFNs contribute to the prevention of viral infection. Lipopolysaccharide (LPS), a specific...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Zhenbang, Zhang, Hui, Zhang, Xiaoxiao, He, Sheng, Dong, Wenjuan, Wang, Xiaoying, Chen, Yaosheng, Liu, Xiaohong, Guo, Chunhe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7109323/
https://www.ncbi.nlm.nih.gov/pubmed/32269560
http://dx.doi.org/10.3389/fmicb.2020.00501
_version_ 1783512931790487552
author Zhu, Zhenbang
Zhang, Hui
Zhang, Xiaoxiao
He, Sheng
Dong, Wenjuan
Wang, Xiaoying
Chen, Yaosheng
Liu, Xiaohong
Guo, Chunhe
author_facet Zhu, Zhenbang
Zhang, Hui
Zhang, Xiaoxiao
He, Sheng
Dong, Wenjuan
Wang, Xiaoying
Chen, Yaosheng
Liu, Xiaohong
Guo, Chunhe
author_sort Zhu, Zhenbang
collection PubMed
description Porcine reproductive and respiratory syndrome virus (PRRSV) has been recognized to induce proinflammatory cytokine production and modulate the host interferon (IFN) system. Proinflammatory cytokines and type I IFNs contribute to the prevention of viral infection. Lipopolysaccharide (LPS), a specific agonist to Toll-like receptor 4 (TLR4), provokes signal transduction and activates immune response in vivo and in vitro. Here we identified LPS inhibited PRRSV infection in porcine alveolar macrophages (PAMs) and in Marc-145 cells. To investigate the possible mechanism, we found TLR4-NF-κB pathway was obviously activated in LPS-treated PAMs at the early stage of PRRSV infection. As a result, the expression of proinflammatory cytokines was strongly induced following LPS and PRRSV co-treatment. Due to the enhanced proinflammatory response, CD163 expression was significantly reduced and a disintegrin and metalloproteinase 17 was activated, which promotes the cleavage of membrane CD163. Ultimately, CD163 down-regulation led to the suppression of PRRSV replication. Our data demonstrate that LPS has an impact on PRRSV infection via inflammation response, which provides a new insight of inflammation-mediated antiviral immunity and a new strategy to control PRRSV infection.
format Online
Article
Text
id pubmed-7109323
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-71093232020-04-08 Lipopolysaccharide Downregulates CD163 Expression to Inhibit PRRSV Infection via TLR4-NF-κB Pathway Zhu, Zhenbang Zhang, Hui Zhang, Xiaoxiao He, Sheng Dong, Wenjuan Wang, Xiaoying Chen, Yaosheng Liu, Xiaohong Guo, Chunhe Front Microbiol Microbiology Porcine reproductive and respiratory syndrome virus (PRRSV) has been recognized to induce proinflammatory cytokine production and modulate the host interferon (IFN) system. Proinflammatory cytokines and type I IFNs contribute to the prevention of viral infection. Lipopolysaccharide (LPS), a specific agonist to Toll-like receptor 4 (TLR4), provokes signal transduction and activates immune response in vivo and in vitro. Here we identified LPS inhibited PRRSV infection in porcine alveolar macrophages (PAMs) and in Marc-145 cells. To investigate the possible mechanism, we found TLR4-NF-κB pathway was obviously activated in LPS-treated PAMs at the early stage of PRRSV infection. As a result, the expression of proinflammatory cytokines was strongly induced following LPS and PRRSV co-treatment. Due to the enhanced proinflammatory response, CD163 expression was significantly reduced and a disintegrin and metalloproteinase 17 was activated, which promotes the cleavage of membrane CD163. Ultimately, CD163 down-regulation led to the suppression of PRRSV replication. Our data demonstrate that LPS has an impact on PRRSV infection via inflammation response, which provides a new insight of inflammation-mediated antiviral immunity and a new strategy to control PRRSV infection. Frontiers Media S.A. 2020-03-25 /pmc/articles/PMC7109323/ /pubmed/32269560 http://dx.doi.org/10.3389/fmicb.2020.00501 Text en Copyright © 2020 Zhu, Zhang, Zhang, He, Dong, Wang, Chen, Liu and Guo. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Microbiology
Zhu, Zhenbang
Zhang, Hui
Zhang, Xiaoxiao
He, Sheng
Dong, Wenjuan
Wang, Xiaoying
Chen, Yaosheng
Liu, Xiaohong
Guo, Chunhe
Lipopolysaccharide Downregulates CD163 Expression to Inhibit PRRSV Infection via TLR4-NF-κB Pathway
title Lipopolysaccharide Downregulates CD163 Expression to Inhibit PRRSV Infection via TLR4-NF-κB Pathway
title_full Lipopolysaccharide Downregulates CD163 Expression to Inhibit PRRSV Infection via TLR4-NF-κB Pathway
title_fullStr Lipopolysaccharide Downregulates CD163 Expression to Inhibit PRRSV Infection via TLR4-NF-κB Pathway
title_full_unstemmed Lipopolysaccharide Downregulates CD163 Expression to Inhibit PRRSV Infection via TLR4-NF-κB Pathway
title_short Lipopolysaccharide Downregulates CD163 Expression to Inhibit PRRSV Infection via TLR4-NF-κB Pathway
title_sort lipopolysaccharide downregulates cd163 expression to inhibit prrsv infection via tlr4-nf-κb pathway
topic Microbiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7109323/
https://www.ncbi.nlm.nih.gov/pubmed/32269560
http://dx.doi.org/10.3389/fmicb.2020.00501
work_keys_str_mv AT zhuzhenbang lipopolysaccharidedownregulatescd163expressiontoinhibitprrsvinfectionviatlr4nfkbpathway
AT zhanghui lipopolysaccharidedownregulatescd163expressiontoinhibitprrsvinfectionviatlr4nfkbpathway
AT zhangxiaoxiao lipopolysaccharidedownregulatescd163expressiontoinhibitprrsvinfectionviatlr4nfkbpathway
AT hesheng lipopolysaccharidedownregulatescd163expressiontoinhibitprrsvinfectionviatlr4nfkbpathway
AT dongwenjuan lipopolysaccharidedownregulatescd163expressiontoinhibitprrsvinfectionviatlr4nfkbpathway
AT wangxiaoying lipopolysaccharidedownregulatescd163expressiontoinhibitprrsvinfectionviatlr4nfkbpathway
AT chenyaosheng lipopolysaccharidedownregulatescd163expressiontoinhibitprrsvinfectionviatlr4nfkbpathway
AT liuxiaohong lipopolysaccharidedownregulatescd163expressiontoinhibitprrsvinfectionviatlr4nfkbpathway
AT guochunhe lipopolysaccharidedownregulatescd163expressiontoinhibitprrsvinfectionviatlr4nfkbpathway